191 related articles for article (PubMed ID: 2358669)
1. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction.
Kennedy MK; Tan LJ; Dal Canto MC; Miller SD
J Immunol; 1990 Jul; 145(1):117-26. PubMed ID: 2358669
[TBL] [Abstract][Full Text] [Related]
2. Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice.
Kennedy MK; Dal Canto MC; Trotter JL; Miller SD
J Immunol; 1988 Nov; 141(9):2986-93. PubMed ID: 2459237
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
Tan LJ; Kennedy MK; Miller SD
J Immunol; 1992 May; 148(9):2748-55. PubMed ID: 1374098
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance.
Tan LJ; Kennedy MK; Dal Canto MC; Miller SD
J Immunol; 1991 Sep; 147(6):1797-802. PubMed ID: 1716280
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
7. Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction.
Miller SD; Tan LJ; Kennedy MK; Dal Canto MC
Ann N Y Acad Sci; 1991 Dec; 636():79-94. PubMed ID: 1724364
[TBL] [Abstract][Full Text] [Related]
8. Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats.
Malotky MK; Pope L; Miller SD
J Immunol; 1994 Jul; 153(2):841-51. PubMed ID: 7517425
[TBL] [Abstract][Full Text] [Related]
9. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism.
Vandenbark AA; Celnik B; Vainiene M; Miller SD; Offner H
J Immunol; 1995 Dec; 155(12):5861-7. PubMed ID: 7499876
[TBL] [Abstract][Full Text] [Related]
10. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease.
Cua DJ; Hinton DR; Stohlman SA
J Immunol; 1995 Oct; 155(8):4052-9. PubMed ID: 7561116
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
12. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion.
Tan LJ; Vanderlugt CL; McRae BL; Miller SD
Autoimmunity; 1998; 27(1):13-28. PubMed ID: 9482204
[TBL] [Abstract][Full Text] [Related]
15. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.
Karussis DM; Slavin S; Lehmann D; Mizrachi-Koll R; Abramsky O; Ben-Nun A
J Immunol; 1992 Mar; 148(6):1693-8. PubMed ID: 1541813
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis.
Karandikar NJ; Vanderlugt CL; Eagar T; Tan L; Bluestone JA; Miller SD
J Immunol; 1998 Jul; 161(1):192-9. PubMed ID: 9647224
[TBL] [Abstract][Full Text] [Related]
17. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins.
Miller SD; Clatch RJ; Pevear DC; Trotter JL; Lipton HL
J Immunol; 1987 Jun; 138(11):3776-84. PubMed ID: 2438327
[TBL] [Abstract][Full Text] [Related]
18. Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice.
Bernard CC
Clin Exp Immunol; 1977 Jul; 29(1):100-9. PubMed ID: 302168
[TBL] [Abstract][Full Text] [Related]
19. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.
Miller SD; Gerety SJ; Kennedy MK; Peterson JD; Trotter JL; Tuohy VK; Waltenbaugh C; Dal Canto MC; Lipton HL
J Neuroimmunol; 1990 Jan; 26(1):9-23. PubMed ID: 1688446
[TBL] [Abstract][Full Text] [Related]
20. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
Matejuk A; Buenafe AC; Dwyer J; Ito A; Silverman M; Zamora A; Subramanian S; Vandenbark AA; Offner H
J Neurosci Res; 2003 Jan; 71(1):89-103. PubMed ID: 12478617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
